CNS vs GBDC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

CNS

59.9
AI Score
VS
CNS Wins

GBDC

58.2
AI Score

Investment Advisor Scores

CNS

60score
Recommendation
HOLD

GBDC

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS GBDC Winner
Forward P/E 18.4502 9.7656 GBDC
PEG Ratio 1.6881 1.395 GBDC
Revenue Growth 12.2% -14.0% CNS
Earnings Growth 31.9% -35.1% CNS
Tradestie Score 59.9/100 58.2/100 CNS
Profit Margin 28.8% 21.4% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% GBDC 1M: -1.8% · 3M: -1.2%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

GBDC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.3 · Price: $12.72

Fundamentals Snapshot

Metric CNS GBDC
Market Cap — —
Forward P/E 18.4 10.0
Trailing P/E 22.4 19.1
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.8%
EPS 3.26 0.66
Dividend Yield 0.04% 0.11%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.